Surgery Partners, Inc. (SGRY)

Data as of Aug 20, 2026, from SEC Form 4 filings.

Net insider buying (90d)Watch SGRY

See up to 3 months of SGRY. The 7-day demo opens the 1M and 3M ranges and puts SGRY on your watchlist.

Latest SGRY insider trades

Teresa Deluca - Director
Open-market purchase$161K
Aug 18, 2026
Teresa Deluca - Director

About Surgery Partners, Inc. (SGRY)

The SEC lists Surgery Partners, Inc. under CIK 0001638833, in general medical and surgical hospitals, nec. We track it alongside the rest of the Health Care sector.

Sector: Health Care

SEC filings for SGRY on EDGAR

SGRY Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market purchase	2	21,250	$305K

SGRY insider transactions (Form 4)

31 Form 4 filings on record, the earliest from Dec 16, 2024, newest first. Filing history page 1 of 2.

Date	Insider	Transaction	Security	Shares	Price	Value
Aug 18, 2026	Teresa Deluca - Director	Open-market purchase	Common Stock	11,250	$14.33^{footnote F1}	$161K
Footnote F1 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased… Full note on SEC EDGAR
Aug 18, 2026	Teresa Deluca - Director	Open-market purchase	Common Stock	10,000	$14.35^{footnote F1}	$144K
Footnote F1 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased… Full note on SEC EDGAR
Jun 18, 2026	Blair E. Hendrix - Director	Grant or award	Common Stock	34,364^{footnote F1}	$14.55	$500K
Footnote F1 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on June 18, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date.
Jun 5, 2026	Blair E. Hendrix - Director	Grant or award	Common Stock	11,670^{footnote F1}	$13.71	$160K
Footnote F1 (shares): Shares will vest on June 5, 2027.
Jun 5, 2026	John A. Deane - Director	Grant or award	Common Stock	11,670^{footnote F1}	$13.71	$160K
Footnote F1 (shares): Shares will vest on June 5, 2027.
Jun 5, 2026	Laura L. Forese - Director	Grant or award	Common Stock	11,670^{footnote F1}	$13.71	$160K
Footnote F1 (shares): Shares will vest on June 5, 2027.
Jun 5, 2026	Clifford G. Adlerz - Director	Grant or award	Common Stock	11,670^{footnote F1}	$13.71	$160K
Footnote F1 (shares): Shares will vest on June 5, 2027.
Jun 5, 2026	Lloyd H. Dean - Director	Grant or award	Common Stock	11,670^{footnote F1}	$13.71	$160K
Footnote F1 (shares): Shares will vest on June 5, 2027.
Jun 5, 2026	Teresa Deluca - Director	Grant or award	Common Stock	11,670^{footnote F1}	$13.71	$160K
Footnote F1 (shares): Shares will vest on June 5, 2027.
Jun 5, 2026	Brent Turner - Director	Grant or award	Common Stock	11,670^{footnote F1}	$13.71	$160K
Footnote F1 (shares): Shares will vest on June 5, 2027.
Mar 13, 2026	Danielle Burkhalter - Officer	Open-market sale	Common Stock	3,469^{footnote F1}	$12.83	$45K
Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 4, 2026.
Mar 13, 2026	Marissa Brittenham - Officer	Open-market sale	Common Stock	3,657^{footnote F1}	$12.54	$46K
Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 4, 2026.
Mar 16, 2026	David T. Doherty - Officer	Open-market sale	Common Stock	8,867^{footnote F1}	$12.50^{footnote F2}	$111K
Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 4, 2026. Footnote F2 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at… Full note on SEC EDGAR
Mar 16, 2026	Jason Eric Evans - Officer	Open-market sale	Common Stock	20,400^{footnote F1}	$12.47^{footnote F2}	$254K
Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 4, 2026. Footnote F2 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at… Full note on SEC EDGAR
Mar 12, 2026	Jennifer Baldock - Officer	Open-market sale	Common Stock	5,798^{footnote F1}	$13.17^{footnote F2}	$76K
Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 4, 2026. Footnote F2 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at… Full note on SEC EDGAR
Mar 6, 2026	Jason Eric Evans - Officer	Open-market sale	Common Stock	11,462^{footnote F1}	$13.79^{footnote F2}	$158K
Mar 5, 2026	Jason Eric Evans - Officer	Grant or award	Common Stock	141,743^{footnote F3}	$14.11	$2.00M
Mar 5, 2026	Jason Eric Evans - Officer	Grant or award	Common Stock	136,363^{footnote F4}	$14.11	$1.92M
Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2026 and March 2, 2026. Footnote F2 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at… Full note on SEC EDGAR Footnote F3 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date. Footnote F4 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date.
Mar 5, 2026	David T. Doherty - Officer	Grant or award	Common Stock	30,501^{footnote F5}	$14.11	$430K
Mar 6, 2026	David T. Doherty - Officer	Open-market sale	Common Stock	14,574^{footnote F1}	$13.84^{footnote F2}	$202K
Mar 5, 2026	David T. Doherty - Officer	Grant or award	Common Stock	56,697^{footnote F3}	$14.11	$800K
Mar 5, 2026	David T. Doherty - Officer	Grant or award	Common Stock	54,545^{footnote F4}	$14.11	$770K
Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2026 and March 2, 2026. Footnote F2 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at… Full note on SEC EDGAR Footnote F3 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date. Footnote F4 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date. Footnote F5 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the second anniversary of the Grant Date.
Mar 5, 2026	Jennifer Baldock - Officer	Grant or award	Common Stock	42,523^{footnote F1}	$14.11	$600K
Mar 5, 2026	Jennifer Baldock - Officer	Grant or award	Common Stock	40,909^{footnote F2}	$14.11	$577K
Mar 5, 2026	Jennifer Baldock - Officer	Grant or award	Common Stock	22,875^{footnote F3}	$14.11	$323K
Mar 6, 2026	Jennifer Baldock - Officer	Open-market sale	Common Stock	10,082^{footnote F4}	$13.70	$138K
Footnote F1 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date. Footnote F2 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date. Footnote F3 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the second anniversary of the Grant Date. Footnote F4 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2025 and March 2, 2025.
Mar 5, 2026	Danielle Burkhalter - Officer	Grant or award	Common Stock	9,150^{footnote F5}	$14.11	$129K
Mar 6, 2026	Danielle Burkhalter - Officer	Open-market sale	Common Stock	7,736^{footnote F1}	$13.60^{footnote F2}	$105K
Mar 5, 2026	Danielle Burkhalter - Officer	Grant or award	Common Stock	17,717^{footnote F3}	$14.11	$250K
Mar 5, 2026	Danielle Burkhalter - Officer	Grant or award	Common Stock	16,363^{footnote F4}	$14.11	$231K
Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2026 and March 2, 2026. Footnote F2 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at… Full note on SEC EDGAR Footnote F3 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date. Footnote F4 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date. Footnote F5 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the second anniversary of the Grant Date.
Mar 5, 2026	William Trenton Webb - Officer	Grant or award	Common Stock	11,438^{footnote F5}	$14.11	$161K
Mar 6, 2026	William Trenton Webb - Officer	Open-market sale	Common Stock	272^{footnote F1}	$13.93^{footnote F2}	$4K
Mar 5, 2026	William Trenton Webb - Officer	Open-market sale	Common Stock	1,794^{footnote F3}	$13.86^{footnote F2}	$25K
Mar 5, 2026	William Trenton Webb - Officer	Grant or award	Common Stock	20,454^{footnote F4}	$14.11	$289K
Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 2, 2026. Footnote F2 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at… Full note on SEC EDGAR Footnote F3 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2026. Footnote F4 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date. Footnote F5 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the second anniversary of the Grant Date.
Mar 5, 2026	Marissa Brittenham - Officer	Grant or award	Common Stock	17,717^{footnote F2}	$14.11	$250K
Mar 5, 2026	Marissa Brittenham - Officer	Grant or award	Common Stock	16,363^{footnote F3}	$14.11	$231K
Mar 5, 2026	Marissa Brittenham - Officer	Grant or award	Common Stock	9,150^{footnote F4}	$14.11	$129K
Mar 6, 2026	Marissa Brittenham - Officer	Open-market sale	Common Stock	8,785^{footnote F1}	$13.70	$120K
Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2026 and March 2, 2026. Footnote F2 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date. Footnote F3 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date. Footnote F4 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the second anniversary of the Grant Date.
Mar 5, 2026	Justin Robert Oppenheimer - Officer	Grant or award	Common Stock	42,523^{footnote F1}	$14.11	$600K
Footnote F1 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date.
Jan 13, 2026	Justin Robert Oppenheimer - Officer	Grant or award	Common Stock	77,736^{footnote F1}	$16.08	$1.25M
Footnote F1 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on January 13, 2026 (the "Grant Date"). The RSAs vest in one installment on the first anniversary of the Grant Date.
Sep 4, 2025	Harrison R. Bane - Officer	Open-market sale	Common Stock	5,726	$22.48	$129K
Sep 4, 2025	Harrison R. Bane - Officer	Open-market sale	Common Stock	3,613	$22.48	$81K
Aug 11, 2025	Teresa Deluca - Director	Open-market sale	Common Stock	20,018	$22.74	$455K
Aug 11, 2025	Patricia Anne Maryland - Director	Open-market sale	Common Stock	0	$0.00	-
Aug 8, 2025	David T. Doherty - Officer	Open-market sale	Common Stock	47,491	$23.39	$1.11M
Jun 10, 2025	Clifford G. Adlerz - Director	Grant or award	Common Stock	6,861	$23.32	$160K
Jun 10, 2025	Blair E. Hendrix - Director	Grant or award	Common Stock	6,861	$23.32	$160K
Jun 10, 2025	Brent Turner - Director	Grant or award	Common Stock	6,861	$23.32	$160K

Recent SGRY Form 8-K filings

Read SGRY company news

Sep 17, 2026Item 2.01, 9.01

Read the filing on SEC EDGAR

Aug 10, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

Jul 24, 2026Item 1.01, 7.01, 9.01

Read the filing on SEC EDGAR

Jun 5, 2026Item 5.07

SGRY insider trading FAQ

What is the latest insider trade for SGRY?

Surgery Partners, Inc. (SGRY) had 2 insider filings in the last 90 days, with the most recent on 2026-08-20. The full record for SGRY runs to 31 Form 4 filings, the earliest from 2024-12-16. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying SGRY stock?

2 insider purchases of SGRY were filed in the last 90 days, totaling $305K.

How many insiders are selling SGRY stock?

No insider sales of SGRY were filed in the last 90 days. 17 sales are on record for this company.

Where can I see SGRY SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects SGRY Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Aug 20, 2026 - Teresa Deluca view on EDGAR
Aug 19, 2026 - Teresa Deluca view on EDGAR
Jul 14, 2026 - Blair E. Hendrix view on EDGAR
Jun 10, 2026 - Blair E. Hendrix view on EDGAR
Jun 9, 2026 - John A. Deane view on EDGAR
Jun 9, 2026 - Laura L. Forese view on EDGAR
Jun 9, 2026 - Clifford G. Adlerz view on EDGAR
Jun 9, 2026 - Lloyd H. Dean view on EDGAR
Jun 9, 2026 - Teresa Deluca view on EDGAR

Related companies with recent insider activity

Learn more

How to read insider buying signals: What an open-market purchase by an insider can and cannot tell you.
Insider activity in Health Care: Where SGRY's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow SGRY with a 7-day demo

SGRY on your watchlist
Every SGRY Form 4 filing on record
Up to 3 months of SGRY price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market purchase

21,250

$305K

Date

Insider

Transaction

Security

Price

Value

Aug 18, 2026

Teresa Deluca - Director

Open-market purchase

Common Stock

11,250

$14.33^{footnote F1}

$161K

Footnote F1 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased… Full note on SEC EDGAR

Aug 18, 2026

Teresa Deluca - Director

Open-market purchase

Common Stock

10,000

$14.35^{footnote F1}

$144K

Footnote F1 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased… Full note on SEC EDGAR

Jun 18, 2026

Blair E. Hendrix - Director

Grant or award

Common Stock

34,364^{footnote F1}

$14.55

$500K

Footnote F1 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on June 18, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date.

Jun 5, 2026

Blair E. Hendrix - Director

Grant or award

Common Stock

11,670^{footnote F1}

$13.71

$160K

Footnote F1 (shares): Shares will vest on June 5, 2027.

Jun 5, 2026

John A. Deane - Director

Grant or award

Common Stock

11,670^{footnote F1}

$13.71

$160K

Footnote F1 (shares): Shares will vest on June 5, 2027.

Jun 5, 2026

Laura L. Forese - Director

Grant or award

Common Stock

11,670^{footnote F1}

$13.71

$160K

Footnote F1 (shares): Shares will vest on June 5, 2027.

Jun 5, 2026

Clifford G. Adlerz - Director

Grant or award

Common Stock

11,670^{footnote F1}

$13.71

$160K

Footnote F1 (shares): Shares will vest on June 5, 2027.

Jun 5, 2026

Lloyd H. Dean - Director

Grant or award

Common Stock

11,670^{footnote F1}

$13.71

$160K

Footnote F1 (shares): Shares will vest on June 5, 2027.

Jun 5, 2026

Teresa Deluca - Director

Grant or award

Common Stock

11,670^{footnote F1}

$13.71

$160K

Footnote F1 (shares): Shares will vest on June 5, 2027.

Jun 5, 2026

Brent Turner - Director

Grant or award

Common Stock

11,670^{footnote F1}

$13.71

$160K

Footnote F1 (shares): Shares will vest on June 5, 2027.

Mar 13, 2026

Danielle Burkhalter - Officer

Open-market sale

Common Stock

3,469^{footnote F1}

$12.83

$45K

Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 4, 2026.

Mar 13, 2026

Marissa Brittenham - Officer

Open-market sale

Common Stock

3,657^{footnote F1}

$12.54

$46K

Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 4, 2026.

Mar 16, 2026

David T. Doherty - Officer

Open-market sale

Common Stock

8,867^{footnote F1}

$12.50^{footnote F2}

$111K

Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 4, 2026.
Footnote F2 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at… Full note on SEC EDGAR

Mar 16, 2026

Jason Eric Evans - Officer

Open-market sale

Common Stock

20,400^{footnote F1}

$12.47^{footnote F2}

$254K

Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 4, 2026.
Footnote F2 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at… Full note on SEC EDGAR

Mar 12, 2026

Jennifer Baldock - Officer

Open-market sale

Common Stock

5,798^{footnote F1}

$13.17^{footnote F2}

$76K

Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 4, 2026.
Footnote F2 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at… Full note on SEC EDGAR

Mar 6, 2026

Jason Eric Evans - Officer

Open-market sale

Common Stock

11,462^{footnote F1}

$13.79^{footnote F2}

$158K

Mar 5, 2026

Jason Eric Evans - Officer

Grant or award

Common Stock

141,743^{footnote F3}

$14.11

$2.00M

Mar 5, 2026

Jason Eric Evans - Officer

Grant or award

Common Stock

136,363^{footnote F4}

$14.11

$1.92M

Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2026 and March 2, 2026.
Footnote F2 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at… Full note on SEC EDGAR
Footnote F3 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date.
Footnote F4 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date.

Mar 5, 2026

David T. Doherty - Officer

Grant or award

Common Stock

30,501^{footnote F5}

$14.11

$430K

Mar 6, 2026

David T. Doherty - Officer

Open-market sale

Common Stock

14,574^{footnote F1}

$13.84^{footnote F2}

$202K

Mar 5, 2026

David T. Doherty - Officer

Grant or award

Common Stock

56,697^{footnote F3}

$14.11

$800K

Mar 5, 2026

David T. Doherty - Officer

Grant or award

Common Stock

54,545^{footnote F4}

$14.11

$770K

Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2026 and March 2, 2026.
Footnote F2 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at… Full note on SEC EDGAR
Footnote F3 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date.
Footnote F4 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date.
Footnote F5 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the second anniversary of the Grant Date.

Mar 5, 2026

Jennifer Baldock - Officer

Grant or award

Common Stock

42,523^{footnote F1}

$14.11

$600K

Mar 5, 2026

Jennifer Baldock - Officer

Grant or award

Common Stock

40,909^{footnote F2}

$14.11

$577K

Mar 5, 2026

Jennifer Baldock - Officer

Grant or award

Common Stock

22,875^{footnote F3}

$14.11

$323K

Mar 6, 2026

Jennifer Baldock - Officer

Open-market sale

Common Stock

10,082^{footnote F4}

$13.70

$138K

Footnote F1 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date.
Footnote F2 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date.
Footnote F3 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the second anniversary of the Grant Date.
Footnote F4 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2025 and March 2, 2025.

Mar 5, 2026

Danielle Burkhalter - Officer

Grant or award

Common Stock

9,150^{footnote F5}

$14.11

$129K

Mar 6, 2026

Danielle Burkhalter - Officer

Open-market sale

Common Stock

7,736^{footnote F1}

$13.60^{footnote F2}

$105K

Mar 5, 2026

Danielle Burkhalter - Officer

Grant or award

Common Stock

17,717^{footnote F3}

$14.11

$250K

Mar 5, 2026

Danielle Burkhalter - Officer

Grant or award

Common Stock

16,363^{footnote F4}

$14.11

$231K

Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2026 and March 2, 2026.
Footnote F2 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at… Full note on SEC EDGAR
Footnote F3 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date.
Footnote F4 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date.
Footnote F5 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the second anniversary of the Grant Date.

Mar 5, 2026

William Trenton Webb - Officer

Grant or award

Common Stock

11,438^{footnote F5}

$14.11

$161K

Mar 6, 2026

William Trenton Webb - Officer

Open-market sale

Common Stock

272^{footnote F1}

$13.93^{footnote F2}

$4K

Mar 5, 2026

William Trenton Webb - Officer

Open-market sale

Common Stock

1,794^{footnote F3}

$13.86^{footnote F2}

$25K

Mar 5, 2026

William Trenton Webb - Officer

Grant or award

Common Stock

20,454^{footnote F4}

$14.11

$289K

Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 2, 2026.
Footnote F2 (price): The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at… Full note on SEC EDGAR
Footnote F3 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2026.
Footnote F4 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date.
Footnote F5 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the second anniversary of the Grant Date.

Mar 5, 2026

Marissa Brittenham - Officer

Grant or award

Common Stock

17,717^{footnote F2}

$14.11

$250K

Mar 5, 2026

Marissa Brittenham - Officer

Grant or award

Common Stock

16,363^{footnote F3}

$14.11

$231K

Mar 5, 2026

Marissa Brittenham - Officer

Grant or award

Common Stock

9,150^{footnote F4}

$14.11

$129K

Mar 6, 2026

Marissa Brittenham - Officer

Open-market sale

Common Stock

8,785^{footnote F1}

$13.70

$120K

Footnote F1 (shares): Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2026 and March 2, 2026.
Footnote F2 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date.
Footnote F3 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date.
Footnote F4 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the second anniversary of the Grant Date.

Mar 5, 2026

Justin Robert Oppenheimer - Officer

Grant or award

Common Stock

42,523^{footnote F1}

$14.11

$600K

Footnote F1 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date.

Jan 13, 2026

Justin Robert Oppenheimer - Officer

Grant or award

Common Stock

77,736^{footnote F1}

$16.08

$1.25M

Footnote F1 (shares): Represents restricted stock awards ("RSAs") granted to the reporting person on January 13, 2026 (the "Grant Date"). The RSAs vest in one installment on the first anniversary of the Grant Date.

Sep 4, 2025

Harrison R. Bane - Officer

Open-market sale

Common Stock

5,726

$22.48

$129K

Sep 4, 2025

Harrison R. Bane - Officer

Open-market sale

Common Stock

3,613

$22.48

$81K

Aug 11, 2025

Teresa Deluca - Director

Open-market sale

Common Stock

20,018

$22.74

$455K

Aug 11, 2025

Patricia Anne Maryland - Director

Open-market sale

Common Stock

$0.00

Aug 8, 2025

David T. Doherty - Officer

Open-market sale

Common Stock

47,491

$23.39

$1.11M

Jun 10, 2025

Clifford G. Adlerz - Director

Grant or award

Common Stock

6,861

$23.32

$160K

Jun 10, 2025

Blair E. Hendrix - Director

Grant or award

Common Stock

6,861

$23.32

$160K

Jun 10, 2025

Brent Turner - Director

Grant or award

Common Stock

6,861

$23.32

$160K